| Date | Form | Description | Docs | XBRL | Pages |
| 01/03/25 | SCHEDULE 13D/A |
|
3 | ||
| 01/03/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/03/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/03/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/03/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/03/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 11/08/24 | 8-K | Current report filing |
|
|
5 |
| 10/23/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 09/06/24 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
19 |
| 08/01/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 |
Latest News & Events
Anixa Biosciences Chairman and CEO Discusses Pioneering CAR-T Cell Therapy and Breast Cancer Vaccine in Alpha Wolf Trading Interview
Read More...Anixa Biosciences to Present at the 18th Annual European Life Sciences CEO Forum
Read More...Anixa Biosciences' Chairman & CEO Dr. Amit Kumar Featured on CW39's H-Town Live to Discuss the Future of Breast Cancer Prevention
Read More...